Go back

Autumn windfall for life sciences

The UK government has earmarked £100 million for life sciences research infrastructure as part of an update to its Strategy for UK Life Sciences, originally launched in December 2011. The government says the £100m will be split between three projects: the UK Regenerative Medicine Platform’s work on imaging, cell-manufacture facilities and clean-room technologies; synthetic biology centres; and a facility for the manufacture of biologic medicines. The money is part of the £600m announced for science in the Chancellor’s Autumn Statement.

The announcement was welcomed by the UK life sciences industry. BioIndustry Association chief executive Steve Bates said in a statement that the funding “will help bioscience companies in the UK bring innovative new treatments to patients sooner”.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.